Utah Medical Products, Inc.
Exhibit 12 to Registration Statement on Form S-3
Calculation of ratio of earnings to fixed charges pursuant to Item 503(d) of Regulation S-K
	Nine months
	ended		Year ended December 31,
	30-Sep-12		2011		2010		2009		2008		2007
Fixed charges
(a) interest expensed and capitalized	$	516,469	$	859,366	$	25,077	$	51,088	$	198,154	$	270,315
(b)  amortized premiums, discounts and capitalized expenses related to indebtedness		-		-		-		-		-		-
(c) estimated interest within rental expense		92,731		73,390		30,956		56,204		57,122		56,048
(d)  preference security dividend requirements of subsidiaries		-		-		-		-		-		-
Total fixed charges	$	609,200	$	932,756	$	56,033	$	107,292	$	255,276	$	326,363
Earnings
Total of:
(a)  Pretax income from continuing operations:	$	11,215,358	$	11,079,889	$	9,040,579	$	9,579,656	$	10,776,683	$	12,038,193
(b)  fixed charges		609,200		932,756		56,033		107,292		255,276		326,363
(c)  amortization of capitalized interest		-		-		-		-		-		-
(d)  distrubuted income of equity investees		-		-		-		-		-		-
(e)  issuer's share of of pre-tax losses of equity investees		-		-		-		-		-		-
		11,824,558		12,012,645		9,096,612		9,686,948		11,031,959		12,364,556
Less:
(a)  interest capitalized		-		-		-		-		-		-
(b)  preference security dividend requirements of consolidated subsidiaries		-		-		-		-		-		-
(c)  minority interest in pre-tax income of subsidiaries that have not incurred fixed charges		-		-		-		-		-		-
		-		-		-		-		-		-
Total Earnings	$	11,824,558	$	12,012,645	$	9,096,612	$	9,686,948	$	11,031,959	$	12,364,556
Ratio of earnings to fixed charges		19.4		12.9		162.3		90.3		43.2		37.9